# Predicting Outcome in Cervix Carcinoma: a Prospective Study

> **NCT01825005** · — · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 423 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01825005
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2019-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825005, "Predicting Outcome in Cervix Carcinoma: a Prospective Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01825005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
